DOCSLIB.ORG

Research Uses of Peptides from the Manning Lab 1980 – 2019

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Research Uses of Peptides from the Manning Lab 1980 – 2019 Over 3,000 samples have been donated to over 820 investigators (some multiple times) in the U.S. and worldwide for their own independent studies. See listings below. These studies have resulted in over 2,000 publications by these investigators. 1. Professor Roger Acher Laboratoire De Chimie Biologique Faculté des Sciences de l’Université de Paris 96, Boulevard Raspail-Paris V1 FRANCE 2. Eli Y. Adashi, M.D. Obstetrics & Gynecology University of Maryland School of Medicine & Hospital 22 South Greene Street Balitmore, MD 21201 3. Greti Aguilera, M.D. Chief Section on Endocrine Physiology DEB, NICHD, NIH Building 10, Room 10N262 10 Center Drive, MSC 1862 Bethesda, MD 20892-1862 4. Dr. K. Al Barazanji Mechanistic Pharmacology Dept. Vascular Biology SmithKline Beecham Pharmaceuticals The Frythe Welwyn, Hertfordshire, AL6 9AR UNITED KINGDOM 5. H. Elliott Albers, Ph.D. Professor of Biology and Psychology Georgia State University Department of Biology College of Arts and Sciences P.O. Box 4010 Atlanta, GA 30302-4010 6. Saad Al-Damluji, B.Sc., MRCP Lecturer in Endocrinology The Medical College of St. Bartholomew’s Hospital West Smithfield, LONDON, EC1A 7BE ENGLAND 7. Natalie Alexander, Ph.D. Department of Medicine University of Southern California School of Medicine 2025 Zonal Avenue Los Angeles, CA 90033 8. O.F.X. Almeida, Ph.D. Max-Planck-Institut Für Psychiatrie Deutsche Forschungsanstalt Für Psychiatrie Abteilung Neuropharmakologie AM Klopferspitz 18A 8033 Planegg-Martinsried WEST GERMANY 9. Dr. Meenakshi Alreja Associate Professor of Psychiatry and Neurobiology Yale University School of Medicine CMHC 335A, 34 Park Street New Haven, CT 06508 10. Nancy L. Alsip, Ph.D. Department of Physiology and Biophysics Health Sciences Center A-1115 University of Louisville Louisville, KY 40292 11. Dr. Margaret Altemus NIMH Building 10, Room 3D41 9000 Rockville Pike Bethesda, MD 20892 12. Norman Altszuler, Ph.D. NYU Medical Center Department of Pharmacology 550 First Avenue New York, NY 10016 13. Lily Alvarez-Jaimes, B.S. University of Puerto Rico Rio Piedras Campus Department of Biology Gandara Avenue, Julio Garcia Diaz Bldg., Rm. 201 San Juan-Puerto Rico, 00931 PUERTO RICO 14. Janet A. Amico, M.D. Assistant Professor of Medicine University of Pittsburgh School of Medicine Pittsburgh, PA 15261 15. Shimon Amir, Ph.D. Associate Professor 1455 de Maisonneuve Blvd. W. Montreal, QUEBEC H3G 1M8 CANADA 16. Dr. Inder S. Anand, FRCP, D. Phil (Oxon.) Professor of Medicine Department of Veterans Affairs Medical Center One Veterans Drive Minneapolis, MN 55417 17. Henning Keinke Andersen, Ph.D. M&E A/S Lerse Parkalli 40 DK-2100 Copenhagen DENMARK 18. Ferenc A. Antoni, Ph.D. University of Oxford Department of Human Anatomy South Parks Road, OXFORD OX1 3QX GREAT BRITAIN 19. Dr. Anita Aperia, Professor Pediatrics and Develop. Physiol. Karolinska Institutet St. Goran’s Children’s Hospital Box 12500, S-11281 Stockholm SWEDEN 20. Ms. Ede M. Apostolakis Division of Perinatal Biology Loma Linda University Department of Physiology School of Medicine Loma Linda, CA 92350 21. Dr. Antonio Argiolas Assistant Professor Institute of Pharmacology University of Cagliari Via Procell 4 09100 Cagliari ITALY 22. William E. Armstrong, Ph.D. Director, Neuroscience Institute/Center of Excellence Professor and Chair (Interim) Department of Anatomy and Neurobiology University of Tennessee, Memphis 855 Monroe Avenue Memphis, TN 38163 23. Dr. Leonard Arnolda Monash University Department of Medicine Prince Henry’s Hospital St. Kilda Road Melbourne, Victoria 3004 AUSTRALIA 24. Assaf Arnon, Ph.D. Loyola University Medical Center Cardiovascular Institute 2160 South First Avenue Building 110, 5th Floor, Room 5244 Maywood, IL 60153 25. Dr. Yvan Arsenijevic Department De Physiologie Centre Médical Universitaire 9, av. de Champel 1211 Genève 4 SWITZERLAND 26. Ms. M. Dominique Ashen Department of Physiology University of Maryland School of Medicine 660 West Redwood Street Baltimore, MD 21201 27. Ivan Assenmacher, M.D., D.Sc. Professor of Physiology Universite de Montpellier Laboratoire de Neuroendocrinologie Section de Physiologie Place Eugene-Bataillon FRANCE 28. Dr. C.L. Au Department of Physiology The Chinese University of Hong Kong Shatin NT HONG KONG 29. Professor Michel L. Aubert Mirza Hügin-Flores, M.D. Fondation Recherches Medicales 64, Av. de la Roseraie 1205-Geneva SWITZERLAND 30. Ms. Sylvia Audigier Rockefeller University 1230 York Avenue New York, NY 10021 31. Dr. Vivienne J. Ayad University of Bristol Department of Anatomy School of Medical Sciences University Walk Bristol, BS8 1TD UNITED KINGDOM 32. Carin Larsson Backstrom, Ph.D. Head, Cardiovascular Section Department of Pharmacology, R + D KabiVitrum AB S-11287 Stockholm SWEDEN 33. Kwang Jin Baek, M.D., Ph.D. Department of Biochemistry College of Medicine Chung-Ang University Seoul 156-756 SOUTH KOREA 34. Dr. Alex J. Baertschi Department de Biologie Animale Universite de Geneve CH-1211 Geneve 4 SWITZERLAND 35. Professor Mary Ann Baker Division of Biomedial Sciences University of California, Riverside Riverside, CA 92521-0121 36. Sam Baldwin Graduate Student Department of Biochemistry Medical College of Ohio 37. William A. Banks, M.D. VAMC 915 N. Grand Blvd. St. Louis, MO 63106 38. Dr. Carlos M. Baratti, Professor Catedra de Farmacologia Facultad de Farmacia y Bioquimica Universidad de Buenos Aires Junin 956, 5to. piso. RA-1113 Buenos Aires, ARGENTINA 39. Dr. Claude Barberis Centre CNRS-INSERM de Pharmacologie-Endocrinologie Rue de la Cardonille 34094 Montpellier Cedex 5, FRANCE 40. Dr. A. Clifford Barger Robert Henry Pfeiffer Professor of Physiology Harvard Medical School Department of Physiology 25 Shattuck Street Boston, MA 02115 41. Dr. Tom Barth Czechoslovak Academy of Science Institute of Organic Chemistry and Biochemistry Flemingovo naemsti 2 166 10 Praha 6 CSSR 42. Dr. Mariette Barthelmebs Institut de Pharmacologie Faculty de Medecine Universir-Louis Pasteur 11 rue Humann Strasbourg 67085 FRANCE 43. William M. Barron, M.D. Assistant Professor Departments of Medicine and Obstetrics and Gynecology The University of Chicago The Pritzker School of Medicine 5841 S. Maryland Avenue Chicago, IL 60637 44. Dr. Ross Bathgate Institute for Hormone and Fertility Research Grandweg 64 22529 Hamburg GERMANY 45. Dr. Peter H. Baylis Newcastle Health Authority Central Sector The Royal Victoria Infirmary Queen Victoria Road Newcastle Upon Tyne Nel 4LP UNITED KINGDOM 46. Dr. Steven Bealer Department of Pharmacology/Toxicology 30 South 2000 East Room 201 Salt Lake City, UT 84121 47. Thomas R. Beck, M.D. Division of Nephrology Dept. of Medicine, Lakeside Hospital Case Western Reserve University Cleveland, OH 44106 48. Annaliese Beery Psychology Dept. UC Berkeley 3210 Tolman Hall #1650 Berkeley, CA 94720-1650 49. Nira Ben-Jonathan, Ph.D. Professor of Physiology Indiana University School of Medicine VanNuys Medial Science Building 374 635 Barnhill Drive Indianapolis, IN 46202-5120 50. Dr. Carol Bennett-Clarke Department of Anatomy Medical College of Ohio Toledo, Ohio 51. Jean-Louis Beny, Ph.D. Geneva University Department of Zoology and Animal Biology Sciences III, 30 quai E. Ansermet 1211 Geneve 4, SWITZERLAND 52. Dr. Kathleen H. Berecek Department of Physiology and Biophysics The University of Alabama in Birmingham Cardiovascular Research and Training Center University Station Birmingham, AL 35294 53. Barry A. Berkowitz, Ph.D. Associate Director, Pharmacology Research & Development Division Smith Kline & French Laboratories P.O. Box 7929 Philadelphia, PA 19101 54. Dr. Gisela Bethancourt Universidad de Panamá Ciudad Universitaria Octavio Mendez Pereira Estafeta Universitaria Panamá, REP. DE PANAMÁ 55. Daniel Bichet, M.D. Division of Nephrology Hopital du Sacre-Coeur 5400 ouest, boul. Gouin Montreal, Quebec H4J 1C5 CANADA 56. Peter Bie, M.D., Ph.D. University of Copenhagen Institute of Medical Physiology C Blegdamsvej 3C DK-2200 Copenhagen N DENMARK 57. Mariel Birnbaumer, Ph.D. Department of Anesthesiology UCLA School of Medicine Center for the Health Sciences 10833 Le Conte Avenue Los Angeles, CA 90024-1778 58. Vernon S. Bishop, Ph.D. Professor Department of Pharmacology The University of Texas Health Science Center at San Antonio 7703 Floyd Curl Drive San Antonio, TX 78284-7764 59. Professor G.W. Bisset Department of Pharmacology St. Thomas’s Hospital Medical School London SE1 7EH ENGLAND 60. Dr. Ruth Blackburn-Munro Leader, Neuroendocrinology & Behaviour Department of Pharmacology Organon Laboratories Ltd. Bo’ness Road Newhouse, Lanarkshire ML1 5SH Scotland (U.K.) 61. Dr. W.W. Blessing Department of Neurology The New York Hospital Cornell Medical Center 525 East 68th Street New York, NY 10021 62. Floyd E. Bloom, M.D. Director Arthur Vining Davis Center for Behavioral Neurobiology P.O. Box 1809 San Diego, CA 92112 63. Bioq. Mariano M. Boccia Laboratorio de Neurofarmacolgia de Procesos de Memoria Cátedra de Farmacologia – Fac. de Farmacia y Bioquimica Junin 956 5 ˚ Piso 1113 – Capital Federal ARGENTINA 64. Dr. Richard J. Bodnar Department of Psychology Queens College of The City University of New York Flushing, NY 11667 65. Dr. Gerard J. Boer Netherlands Institute for Brain Research P.O. Box 41850 1009 DB Amsterdam THE NETHERLANDS 66. B. Bohus, M.D., Ph.D. Professor and Chairman Laboratorium Voor Dier Fysiologie Biologisch centrum Kerklaan 30 Haren THE NETHERLANDS 67. Dr. D. Bojanic Department of Biochemistry The University of Tennessee Center for the Health Sciences 800 Madison
Recommended publications
  • October 24–26, 2021 2

    October 24–26, 2021 2

    SCIENCE · INNOVATION · POLICIES WORLD HEALTH SUMMIT BERLIN, GERMANY & DIGITAL OCTOBER 24–26, 2021 2 “No-one is safe from COVID-19; “All countries have signed up to Universal no-one is safe until we are all Health Coverage by 2030. But we cannot safe from it. Even those who wait ten years. We need health systems conquer the virus within their that work, before we face an outbreak own borders remain prisoners of something more contagious than within these borders until it is COVID-19; more deadly; or both.” conquered everywhere.” ANTÓNIO GUTERRES Secretary-General, United Nations FRANK-WALTER STEINMEIER Federal President, Germany “We firmly believe that the “All pulling together—this must rights of women and girls be the hallmark of the European are not negotiable.” Health Union. I believe this can NATALIA KANEM be a test case for true global Executive Director, United Nations Population Fund (UNFPA) health compact. The need for leadership is clear and I believe the European Union must as- sume this responsibility.” “The lesson is clear: a strong health URSULA VON DER LEYEN system is a resilient health system. Health President, European Commission systems and preparedness are not only “Governments of countries an investment in the future, they are the that are doing well during foundation of our response today.” the pandemic have not TEDROS ADHANOM GHEBREYESUS Director-General, World Health Organization (WHO) only shown political leader- ship, but also have listened “If we don’t address the concerns and to scientists and followed fears we will not do ourselves a favor. their recommendations.” In the end, it is about how technology SOUMYA SWAMINATHAN Chief Scientist, World Health can be advanced as well as how Organization (WHO) we can make healthcare more human.” BERND MONTAG President and CEO, Siemens Healthineers AG, Germany “The pandemic has brought to light the “Academic collabo ration is importance of digital technologies and in place and is really a how it can radically bridging partnership.
  • World Health Summit Berlin, Germany October 09–11, 2016

    World Health Summit Berlin, Germany October 09–11, 2016

    SCIENCE · INNOVATION · POLICIES WORLD HEALTH SUMMIT BERLIN, GERMANY OC TOBER 09–11, 2016 FEDERAL FOREIGN OFFICE | BERLIN I am convinced the “ World Health Summit will add valuable The World Health Summit impetus and wish all “ is an excellent venue for participants interesting expert discussion on the and enlightening days. health topics that move us Hermann Gröhe Federal Minister of Health, Germany” worldwide. We can expect it to deliver valuable input. Angela Merkel Chancellor of the ” Your involvement and Federal Republic of Germany “ your declarations at this World Health Summit will play an important role in informing the international community. François Hollande President of the French Republic ” FACTS WORLD HEALTH SUMMIT 2016 | 3 3 DAYS · 40 SESSIONS · 250 SPEAKERS From October 9–11, the 8th World Health Summit will once Patronage again draw international experts from academia, politics, Angela Merkel Federal Chancellor of Germany the private sector, and civil society to the German Federal François Hollande Foreign Oce in Berlin. President of France Jean-Claude Juncker At the World Health Summit (WHS), more than 1,500 stakeholders and President of the decision-makers from every field in the healthcare spectrum will work European Commission together to find solutions to global health challenges. Presidents 2016 The world’s foremost strategic forum for global health, it promotes thought Antoine Flahault leadership in science and global health agendas. The World Health Summit University of Geneva was founded in 2009 on the occasion
  • Global Health – Do Think Tanks Matter?

    Global Health – Do Think Tanks Matter?

    Global Health – Do Think Tanks Matter? Organised by the Global Health Programme at the Graduate Institute Biographies of Speakers 13 November 2015 Maison de la paix The Graduate Institute, Geneva WELCOME AND INTRODUCTORY REMARKS BY THE MODERATOR OF THE SESSION ILONA KICKBUSCH Director, Global Health Programme, the Graduate Institute Ilona Kickbusch is the Director of the Global Health Programme at the Graduate Institute of International and Development Studies, Geneva. She is senior advisor to the Regional Directors of the WHO Regional Offices for Europe and the Eastern Mediterranean. She has been deeply involved in the development of the Health 2020 European health policy framework. She is a member of the independent Ebola interim assessment panel of the WHO. In Switzerland, she serves on the executive board of the Careum Foundation and on the expert panel to the Federal Councillor to advise on the implementation of the Swiss Health Strategy 2020. She has contributed to innovation in health in many ways throughout her career and now advises organisations, government agencies and the private sector on policies and strategies to promote health at the national, European and international level. She has worked with the WHO at various levels and in academia as professor at Yale University. She has received honorary doctorates from the Nordic School of Public Health and the University of Girona. She has published widely and is a member of a number of advisory boards in both the academic and health policy arenas. She has received many awards. Her key areas of work relate to Global Health Governance, Health Security, Public Health, Health Promotion, Health Literacy, and Health in All Policies.
  • Annexure 1B 18416

    Annexure 1B 18416

    Annexure 1 B List of taxpayers allotted to State having turnover of more than or equal to 1.5 Crore Sl.No Taxpayers Name GSTIN 1 BROTHERS OF ST.GABRIEL EDUCATION SOCIETY 36AAAAB0175C1ZE 2 BALAJI BEEDI PRODUCERS PRODUCTIVE INDUSTRIAL COOPERATIVE SOCIETY LIMITED 36AAAAB7475M1ZC 3 CENTRAL POWER RESEARCH INSTITUTE 36AAAAC0268P1ZK 4 CO OPERATIVE ELECTRIC SUPPLY SOCIETY LTD 36AAAAC0346G1Z8 5 CENTRE FOR MATERIALS FOR ELECTRONIC TECHNOLOGY 36AAAAC0801E1ZK 6 CYBER SPAZIO OWNERS WELFARE ASSOCIATION 36AAAAC5706G1Z2 7 DHANALAXMI DHANYA VITHANA RAITHU PARASPARA SAHAKARA PARIMITHA SANGHAM 36AAAAD2220N1ZZ 8 DSRB ASSOCIATES 36AAAAD7272Q1Z7 9 D S R EDUCATIONAL SOCIETY 36AAAAD7497D1ZN 10 DIRECTOR SAINIK WELFARE 36AAAAD9115E1Z2 11 GIRIJAN PRIMARY COOPE MARKETING SOCIETY LIMITED ADILABAD 36AAAAG4299E1ZO 12 GIRIJAN PRIMARY CO OP MARKETING SOCIETY LTD UTNOOR 36AAAAG4426D1Z5 13 GIRIJANA PRIMARY CO-OPERATIVE MARKETING SOCIETY LIMITED VENKATAPURAM 36AAAAG5461E1ZY 14 GANGA HITECH CITY 2 SOCIETY 36AAAAG6290R1Z2 15 GSK - VISHWA (JV) 36AAAAG8669E1ZI 16 HASSAN CO OPERATIVE MILK PRODUCERS SOCIETIES UNION LTD 36AAAAH0229B1ZF 17 HCC SEW MEIL JOINT VENTURE 36AAAAH3286Q1Z5 18 INDIAN FARMERS FERTILISER COOPERATIVE LIMITED 36AAAAI0050M1ZW 19 INDU FORTUNE FIELDS GARDENIA APARTMENT OWNERS ASSOCIATION 36AAAAI4338L1ZJ 20 INDUR INTIDEEPAM MUTUAL AIDED CO-OP THRIFT/CREDIT SOC FEDERATION LIMITED 36AAAAI5080P1ZA 21 INSURANCE INFORMATION BUREAU OF INDIA 36AAAAI6771M1Z8 22 INSTITUTE OF DEFENCE SCIENTISTS AND TECHNOLOGISTS 36AAAAI7233A1Z6 23 KARNATAKA CO-OPERATIVE MILK PRODUCER\S FEDERATION
  • Spring 2021 TE TA UN S E ST TH at I F E V a O O E L F a DITAT DEUS

    Spring 2021 TE TA UN S E ST TH at I F E V a O O E L F a DITAT DEUS

    Commencement 2021 Spring 2021 TE TA UN S E ST TH AT I F E V A O O E L F A DITAT DEUS N A E R R S I O Z T S O A N Z E I A R I T G R Y A 1912 1885 ARIZONA STATE UNIVERSITY COMMENCEMENT AND CONVOCATION PROGRAM Spring 2021 May 3, 2021 THE NATIONAL ANTHEM CONTENTS THE STAR-SPANGLED BANNER The National Anthem and O say can you see, by the dawn’s early light, Arizona State University Alma Mater ................................. 2 What so proudly we hailed at the twilight’s last gleaming? Whose broad stripes and bright stars through the perilous fight Letter of Congratulations from the Arizona Board of Regents ............... 5 O’er the ramparts we watched, were so gallantly streaming? History of Honorary Degrees .............................................. 6 And the rockets’ red glare, the bombs bursting in air Gave proof through the night that our flag was still there. Past Honorary Degree Recipients .......................................... 6 O say does that Star-Spangled Banner yet wave Conferring of Doctoral Degrees ............................................ 9 O’er the land of the free and the home of the brave? Sandra Day O’Connor College of Law Convocation ....................... 29 ALMA MATER Conferring of Masters Degrees ............................................ 36 ARIZONA STATE UNIVERSITY Craig and Barbara Barrett Honors College ................................102 Where the bold saguaros Moeur Award ............................................................137 Raise their arms on high, Praying strength for brave tomorrows Graduation with Academic Recognition ..................................157 From the western sky; Summa Cum Laude, 157 Where eternal mountains Magna Cum Laude, 175 Kneel at sunset’s gate, Cum Laude, 186 Here we hail thee, Alma Mater, Arizona State.
  • Detlev Ganten

    Detlev Ganten

    Detlev Ganten * 28. 3. 1941 Lüneburg Der Mediziner Detlev Ganten arbeitet in der Bluthochdruckforschung und über die molekulare Genetik von Herz-Kreislauf-Erkrankungen. 1997/98 war Ganten Präsident der GDNÄ und referierte z. B. 1994 in Hamburg über Die Genetik des Bluthochdrucks: Molekulare Analyse einer Volkskrankheit. Detlev Ganten studierte ab 1962 Medizin in Würzburg, Montpellier (Frankreich) und Tübingen und war an der chirurgischen Abteilung des französischen Krankenhauses in Marrakesch tätig. Das Studium schloss er 1968 mit der Promotion ab. Zwischen 1969 und 1973 hielt er sich für For- schungszwecke am Clinical Research Institute in Montreal auf und erwarb den Doctor of Philosophy (PhD) von der McGill University. 1975 erhielt Ganten einen Ruf an das Pharmakologische Institut der Universität Heidel- berg und war anschließend ab 1992 Gründungsdirektor des Max-Delbrück- Centrums für Molekulare Medizin in Berlin-Buch. Parallel dazu war Ganten bis 2004 Professor für Klinische Pharmakologie am Universitätsklinikum der FU Berlin. In seiner wissenschaftlichen Arbeit beschäftigt sich Ganten insbesondere mit dem hormonalen Renin-Angiotensin-System, das u.a. für die Erhöhung des Blutdrucks verantwortlich ist. Daneben forscht er zur An- wendung transgener Techniken im Bereich der Herz-Kreislauf-Regulation und zu den genetischen Ursachen von Bluthochdruck. Ganten ist Heraus- geber des Journal of Molecular Medicine und des Handbook of Experimental Phar- macology. Außerhalb der wissenschaftlichen und medizinischen Arbeit war Gan- ten von 1993 bis 1998 Mitglied im Wissenschaftsrat der Bundesrepublik Deutschland, saß von 2002 bis 2007 im Nationalen Ethikrat und war von 2004 bis 2008 Vorstandsvorsitzender der Charité. Zwischen 1997 und 2001 war er Präsident der Helmholtz-Gemeinschaft Deutscher Forschungszent- ren.
  • M8 Alliance Expert Meeting on Migrants' and Refugees' Health 23

    M8 Alliance Expert Meeting on Migrants' and Refugees' Health 23

    M8 Alliance Expert Meeting on Migrants’ and Refugees’ Health 23-24 June 2017 Venue: Rectorate Building, Sapienza University of Rome, P.le Aldo Moro 5, Rome Hosted by Sapienza University of Rome in cooperation with Charité – Universitätsmedizin Berlin, the University of Geneva, the University of Montreal, the Université Sorbonne Paris Cité, the Centre Virchow-Villermé for Public Health Paris-Berlin, Tehran University of Medical Sciences and the Italian Society of Migration Medicine Overall Chair: Luciano Saso, Faculty of Pharmacy and Medicine, Vice-Rector for European University Networks Sapienza University, Sapienza's Representative in the M8 Alliance 23 June, 2017 11.00 Conferral of Honorary Doctorate on Prof. Detlev Ganten (Senate Hall, Rectorate Building, 1st floor) 13:00-14:00 Registration and light lunch (Room “Organi Collegiali”, Rectorate Building, ground floor) 14:00 -14:25 Welcome Addresses Eugenio Gaudio, Rector of Sapienza University of Rome Detlev Ganten, President of the World Health Summit, Berlin Delegate of Beatrice Lorenzin, Minister of Health, Italy Susanne Wasum-Rainer, Ambassador, Embassy of the Federal Republic of Germany in Italy Hinrich Thölken, Ambassador, Permanent Representation of the Federal Republic of Germany to the International Organizations in Italy 14:25 -14:45 Introduction Paolo Villari, Director of the Department of Public Health and Infectious Diseases, Sapienza University of Rome Axel Pries, Dean, Charité, Universitätsmedizin Berlin Vincenzo Vullo, Dean of the Faculty of Pharmacy and Medicine, Sapienza University of Rome Sebastiano Filetti, Dean of the Faculty of and Medicine and Dentistry, Sapienza University of Rome Massimo Volpe, Dean of the Faculty of and Medicine and Psychology, Sapienza University of Rome 14:45-17:00 Session 1A.
  • First Year, Sem-1, Mid-2 Marks, 2019

    First Year, Sem-1, Mid-2 Marks, 2019

    I /IV B.Tech First Semester Mid -II Examination ECE (2019-20) Roll number Name of the student English M1 ES BEE PEE C 319126512001 ALLU SAHITYA 15 18 19 18 16 19 319126512002 B VENKATA PADMANABHA RAJU 13 17 20 18 14 19 319126512003 BATTULA KEERTHI 16 20 18 18 12 18 319126512004 BELLANA AIDTYA PATRO 16 14 20 13 12 14 319126512005 B VENKATA SAI YASWANTH 13 5 12 15 8 10 319126512006 BONELA JAYA KISHOR 13 10 14 10 9 12 319126512007 BONGU USHA SRI 16 14 20 15 13 16 319126512008 BORA JAGADEESH 16 20 20 18 13 19 319126512009 BOTTA SREE SAI PREETHAM 14 2 12 7 4 5 319126512010 BUDDHA HARSHA VARDHAN 15 20 16 14 11 13 319126512011 CHAITHANYA TEJA UPPE 12 8 12 8 4 6 319126512012 CHATLA GANESH REDDY 15 15 16 16 12 11 319126512013 EPURI JAYA BHARGAVI VARMA 15 0 9 5 6 6 319126512014 GANTIYADA HEMA KALYANI 14 4 10 4 7 4 319126512015 GEDELA TARUN 14 10 14 11 11 9 319126512016 GIDUTHURI KIRAN SAI 14 7 9 6 6 9 319126512017 GORAPALLI CHAKRADHAR NAIDU 15 20 19 12 13 16 319126512018 GUNDABALA MOHAN VAMSI 14 6 14 10 8 8 319126512019 G JAYANTH NAGA SRI SAI 15 10 16 11 5 7 319126512020 ILLINDRAPARTHI SATHYA SAGAR 15 0 9 12 8 5 319126512021 JAMI DILEEP KUMAR 16 14 20 19 12 13 319126512022 KAKARA JYOTHIR SAI 17 3 15 16 14 13 319126512023 KAMMILA LASYA SRI 18 20 20 17 15 18 319126512024 KANGAVA KUMAR SWAMY 14 2 12 9 4 6 319126512025 KAPARAPU SHYAM 16 18 13 13 13 14 319126512026 KATAKAM SAI CHARAN 13 9 17 11 11 11 319126512027 KOREDLA PREM SAI ESWAR NAIDU 16 20 17 18 14 18 319126512028 KOSIREDDI LOKESH 15 13 9 12 11 10 319126512029 KRAPA TARUN 15 14 12 8 7 17 319126512030
  • 2 of the Collège De France

    2 of the Collège De France

    The Letter 2 of the Collège de France N°2 Academic year 2006-2007 Editorial The Collège de France’s new Scientific and Strategic Orientation Committee (COSS) by Pierre Corvol Administrator ‘Today’s world is seeking references, reasons to marvel, of the Collège de France ambitious motivating projects. With the sole objective of Professor, furthering knowledge, basic research – that essentially holder of the Chair of Experimental Medicine disinterested research which demands real collaboration at international level – is one of the paths on that quest. Science is and will always remain a factor of emancipation for humans the university world through the PhD schools, increasing and it is important today to emphasize that obvious fact. In this relations with foreign universities, and developing research at the context, the Collège de France has a unique position in France Collège itself. Today a progress report is indispensable. The and in Europe but also in the world.’ These are the introductory Collège will be attentive to the COSS’s opinions on these points, lines of the Annual Report of the International Scientific and as these will enable it to focus its strategy on the objectives that Strategic Orientation Committee (COSS) submitted to the the Committee has reviewed and revised. President of the Republic, the Prime Minister and the Collège de France’s supervisory ministries in May 2004. The COSS meeting in March 2007 enabled it to make contact with the members of the extended executive of the The creation of the COSS in 2003, on the Collège’s Collège and certain professors at the Cardinal Lemoine and initiative, stemmed from the wish to benefit from eminent Ulm sites.
  • Commencement April 25, 2021 - May 1, 2021 August 6, 2021 May 1, 2021

    Commencement April 25, 2021 - May 1, 2021 August 6, 2021 May 1, 2021

    Commencement April 25, 2021 - May 1, 2021 August 6, 2021 May 1, 2021 Dear Campbellsville University Graduates: Today is the culmination of years of hard work. You have persevered, but this is not the end; this is the be- ginning of the next steps on your path. Thus, we call this “commencement.” The education you have received and the degree you have earned will serve you well as a foundation for the life you are building. Campbellsville University will always be your home. You have been a student, now you are joining an ev- er-growing family of CU alumni, now numbering over 19,000. For 115 years, Campbellsville University has been training servant leaders. Whatever your degree, we hope you take into the world your passion to serve others, better humanity, and live a life that is undergirded by the Christian values on which Campbellsville University was founded. There are many people who have supported you along your journey. From faculty and staff to family and friends, you have been cheered on by many. Now, it is your turn. As you move into this new phase of your life, be an encourager, a supporter, a cheerleader for those who are traveling the road you just traveled. Take time today to show your gratitude to those who have supported you along your journey by paying it forward to others. Congratulations on your accomplishment! Your dedication has paid off. Go into the world continuing to strive for excellence and creating a better tomorrow. Best now and in the future, H. Keith Spears, Ed.D.
  • World Health Summit Berlin, Germany October 15–17, 2017

    World Health Summit Berlin, Germany October 15–17, 2017

    S ECCI N E · InnOVATION · POLICIES WORLD HEALTH SUMMIT B ERLIN, GERMANY O CTOBER 15–17, 2017 FACTS WORLD HEALTH SUMMIT 2017 | 3 3 DAYS · 40 SESSIONS · 250 SPEAKERS From October 15–17, the 9th World Health Summit will draw Patronage inter national experts from academia, politics, the private sector, Angela Merkel and civil society to Berlin. Chancellor of the Federal Republic of Germany At the World Health Summit (WHS), more than 1,600 stakeholders François Hollande * and decision-makers from over 80 countries and every field in the President of France healthcare spectrum will work together to find solutions to global Jean-Claude Juncker * health challenges. President of the European Commission The world’s foremost strategic forum for global health, it promotes thought leadership in science and advances global health agendas. Presidents 2017 The World Health Summit was founded in 2009 on the occasion of Hélène Boisjoly the 300th anniversary of Berlin’s Charité Hospital. Université de Montréal Detlev Ganten Charité – Universitätsmedizin Berlin PROGRAM STRUCTURE Participants SUNDAY, OCT 15, 2017 • More than 1,600 decision makers 10:30 from over 80 countries on site 13:00 • More than 3,000 people 15:00 worldwide via online live-stream 17:00 WHS OPENING CEREMONY Results • The M8 Alliance Declaration MONDAY, OCT 16, 2017 • Session Reports 9:00 • Statements and recommendations 11:00 made at the WHS are passed on to 13:00 WHS Startup Track National Academies, Governments, 14:00 and International Organizations 16:00 19:00 WHS Night Regional Meetings
  • Curriculum Vitae Professor Dr. Detlev Ganten

    Curriculum Vitae Professor Dr. Detlev Ganten

    Curriculum Vitae Professor Dr. Detlev Ganten Name: Detlev Ganten Born: 28 March 1941 Major scientific interests: Pathophysiology and molecular biology of high blood pressure, Public Health, Bioethics Academic and Professional Career 2010 Guest Professorship, Collège de France, Paris, France since 2009 President World Health Summit; Chairman of Board of Trustees of the Max Planck Institute of Colloids and Interfaces and Max Planck Institute of Molecular Plant Physiology, Germany since 2005 Chairman of the Board, Charité Foundation, Germany 2004 ‐ 2008 Chief Executive Officer, Charité Berlin, Germany 1991 ‐ 2004 Founding Director, Max Delbrück Center for Molecular Medicine (MDC) Berlin‐ Buch, Germany 1975 Professor of Pharmacology, University of Heidelberg, Germany 1973 Ph.D., McGill University, Montreal, Canada 1969 ‐ 1973 Research Fellow, Clinical Research Institute, Université de Montreal, Canada 1968 M.D. degree, University of Tübingen, Germany Project coordination, Membership in collaborative research projects (Selection) since 2011 Board of Trustees, University Paris Sciences Lettres PSL since 2011 Scientific Advisory Board, University Sorbonne Paris Cité since 2009 President of the World Health Summit Nationale Akademie der Wissenschaften Leopoldina www.leopoldina.org 1 since 2009 Chairman of Board of Trustees of the Max Planck Institute of Colloids and Interfaces and Max Planck Institute of Molecular Plant Physiology, Potsdam, Germany since 2009 Scientific Advisory Board, Agence Nationale der Recherche (ANR), Paris, France since